These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11156553)

  • 21. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.
    Ennaceur A; Michalikova S; van Rensburg R; Chazot PL
    Behav Brain Res; 2008 Mar; 188(1):136-53. PubMed ID: 18055029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior.
    Wang KC; Lee YJ; Fan LW; Yang PP; Tao PL; Ho IK; Tien LT
    Brain Res Bull; 2013 Jan; 90():137-41. PubMed ID: 23142328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.
    Micó JA; Prieto R
    CNS Drugs; 2012 Aug; 26(8):637-48. PubMed ID: 22784017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.
    Bian F; Li Z; Offord J; Davis MD; McCormick J; Taylor CP; Walker LC
    Brain Res; 2006 Feb; 1075(1):68-80. PubMed ID: 16460711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat.
    Gower AJ; Falter U; Lamberty Y
    Eur J Pharmacol; 2003 Nov; 481(1):67-74. PubMed ID: 14637176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
    Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain.
    Field MJ; Hughes J; Singh L
    Br J Pharmacol; 2000 Sep; 131(2):282-6. PubMed ID: 10991921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
    Jacobson LH; Cryan JF
    Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxioselective profile of glycineB receptor partial agonist, D-cycloserine, in plus-maze-naïve but not plus-maze-experienced mice.
    Rodgers RJ; Howard K; Stewart S; Waring P; Wright FL
    Eur J Pharmacol; 2010 Nov; 646(1-3):31-7. PubMed ID: 20727880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain.
    Field MJ; Holloman EF; McCleary S; Hughes J; Singh L
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1242-6. PubMed ID: 9316831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemangiosarcoma in mice administered pregabalin: analysis of genotoxicity, tumor incidence, and tumor genetics.
    Pegg D; Bleavins M; Herman J; Wojcinski Z; Graziano M; Henck J; Criswell KA; Anderson T; Duddy S
    Toxicol Sci; 2012 Jul; 128(1):9-21. PubMed ID: 22539615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
    Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
    Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain.
    Gustafsson H; Sandin J
    Eur J Pharmacol; 2009 Mar; 605(1-3):103-8. PubMed ID: 19248226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats.
    Bardin L; Gregoire S; Aliaga M; Malfetes N; Vitton O; Ladure P; Newman-Tancredi A; Depoortère R
    Neurosci Res; 2010 Feb; 66(2):135-40. PubMed ID: 19883699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.
    Micheva KD; Taylor CP; Smith SJ
    Mol Pharmacol; 2006 Aug; 70(2):467-76. PubMed ID: 16641316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.